Welcome to Neurotransmissions, a new First Opinion column on the revolution in dementia. Welcome to Neurotransmissions, a new column on dementia from Jason Karlawish. This is the third in a three-part series on the dramatically changing world of dementia. Read the first and second installments.
Diagnosis is interesting. Treatment is exciting.
I’ve fond memories from early in my career prescribing medications that within minutes relieved patients smothering from congestive heart failure, pulled them back from near death from septic shock, or slowed the progression of their diabetes or heart disease. In my fellowship, my prescription of carbidopa transformed the first patient with Parkinson’s disease I diagnosed. After he went from the “utter misery” of house-bound days to happily walking about the neighborhood with his wife, the couple called me their miracle worker.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
